Enlargement of the foveal avascular zone in diabetic retinopathy after adjunctive intravitreal bevacizumab (Avastin) with pars plana vitrectomy

Journal of Ocular Pharmacology and Therapeutics

Volumn 25, Issue 2, 2009, Pages 173-174

  Jun Lee, Sung ^a   Jun Koh, Hyoung ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; ANGIOGENESIS INHIBITOR; MONOCLONAL ANTIBODY;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIABETES MELLITUS; DIABETIC RETINOPATHY; FLUORESCENCE ANGIOGRAPHY; FOVEAL AVASCULAR ZONE ENLARGEMENT; HUMAN; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; RETINA DISEASE; RETINA FOVEA; VISUAL ACUITY; VITRECTOMY; VITREOUS HEMORRHAGE; HYPERTROPHY; INJECTION; MULTIMODALITY CANCER THERAPY; PATHOLOGY; VASCULARIZATION; VITREOUS BODY;

ADULT; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; COMBINED MODALITY THERAPY; DIABETIC RETINOPATHY; FLUORESCEIN ANGIOGRAPHY; FOVEA CENTRALIS; HUMANS; HYPERTROPHY; INJECTIONS; MALE; VITRECTOMY; VITREOUS BODY; VITREOUS HEMORRHAGE;

EID: 68149153131     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2008.0092     Document Type: Article

References (7)

1. Lee, C.S., and Koh, H.J. Multiple retinal haemorrhages in diabetic retinopathy after adjunctive intravitreal bevacizumab (Avastin) with pars plana vitrectomy. Acta Ophthalmol. 86:812-813, 2008.
2. Chung, E.J., Hong, Y.T., Lee, S.C., Kwon, O.W., and Koh, H.J. Prognostic factors for visual outcome after intravitreal bevacizumab for macular edema due to branch retinal vein occlusion. Graefes Arch. Clin. Exp. Ophthalmol. 246:1241-1247, 2008.
3. Chung, E.J., Roh, M.I., Kwon, O.W., and Koh, H.J. Effects of macular ischemia on the outcome of intravitreal bevacizumab therapy for diabetic macular edema. Retina. 28:957-963, 2008.
4. Neubauer, A.S., Kook, D., Haritoglou, C., et al. Bevacizumab and retinal ischemia. Ophthalmology. 114:2096, 2007.
5. Heinzerling, J.H., and Huerta, S. Bowel perforation from bevacizumab for the treatment of metastatic colon cancer: incidence, etiology, and management. Curr. Surg. 63:334-337, 2006. (Pubitemid 44340939)
6. Scappaticci, F.A., Skillings, J.R., Holden, S.N., et al. Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab. J. Natl. Cancer Inst. 99:1232-1239, 2007.
7. Mourad, J.J., des Guetz, G., Debbabi, H., and Levy, B.I. Blood pressure rise following angiogenesis inhibition by bevacizumab. A crucial role for microcirculation. Ann. Oncol. 19:927-934, 2008.